Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving doxorubicin together with bortezomib works in
treating patients with liver cancer. Drugs used in chemotherapy, such as doxorubicin, work in
different ways to stop tumor cells from dividing so they stop growing or die. Bortezomib may
stop the growth of tumor cells by blocking the enzymes necessary for their growth. Giving
doxorubicin together with bortezomib may kill more tumor cells.